Lodelcizumab

Lodelcizumab is a monoclonal antibody targeting PCSK9. Lodelcizumab can be used for the research of hypercholesterolemia[1].

Product Specifications

CAS Number

[1355338-54-3]

UNSPSC

12352203

Target

PCSK9

Type

Inhibitory Antibodies

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/lodelcizumab.html

Purity

99.89

Solubility

10 mM in DMSO

Smiles

[Lodelcizumab]

Molecular Weight

(145.6 kDa)

References & Citations

[1]Pordy, et al. Anti-PCSK9 inhibitory antibodies for treating patients with hyperlipidemia undergoing lipoprotein apheresis. Patent. WO2017031151 A1.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA502647S 30 µL

VASP Mouse Monoclonal Antibody [Clone ID: OTI4D6]

Ask

View Details

MP200106 200 Reactions

Adam19 Mouse qPCR Primer Pair (NM_009616)

Ask

View Details

MBS9501623-01 1 Kit

Phospho-FER (Tyr402) Colorimetric Cell-Based ELISA Kit

Ask

View Details

MBS9501623-02 5x 1 Kit

Phospho-FER (Tyr402) Colorimetric Cell-Based ELISA Kit

Ask

View Details

MBS7061006 Inquire

Recombinant Saccharomyces cerevisiae Mitochondrial outer membrane protein IML2 (IML2) , partial

Ask

View Details

RM-O121652-01 10 mg

Olaparib Impurity 26

Ask

View Details